Publication | Open Access
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
516
Citations
18
References
2002
Year
Results show evidence of favorable anti-ischemic effects with Ad5-FGF4 compared with placebo, and it appears to be safe. Angiogenic gene transfer with Ad5-FGF4 shows promise as a new therapeutic approach to the treatment of angina pectoris.
| Year | Citations | |
|---|---|---|
Page 1
Page 1